Blog › GLP-1

Sourcing Tirzepatide in Bulk: A B2B Guide to Wholesale and White-Label Supply in the EU

> For business and research-procurement audiences only. Tirzepatide (GLP-1/GIP) is supplied strictly as a laboratory research reagent (Research Use Only). It is not a medicine, supplement or food, and is not intended for human or animal consumption. Nothing below is consumer or medical advice.

For European resellers, contract labs and distributors building a research-peptide catalogue, Tirzepatide sits among the most-requested GLP-1 category references. Sourcing it well is less about the molecule and more about the supply chain: where the stock physically sits, how purity is documented, and how flexibly you can brand and reorder. This guide walks through what a B2B buyer should evaluate.

Why EU-based stock changes the math

The single biggest variable in cross-border peptide procurement is customs. When inventory ships from outside the customs union, lead times become unpredictable and shipments can stall at the border. Peptworks holds Tirzepatide stock already inside the EU, so orders move intra-community in 3-5 business days with no customs for EU destinations. For a reseller promising delivery windows to their own customers, that predictability is the product.

Bulk vs white-label: two ways to buy

There are two procurement routes. Bulk means unbranded vials you receive as-is, ideal if you repackage or supply other labs. White-label means the vials are labelled with *your* brand and boxed, so the product arrives shelf-ready under your identity. You choose per order.

The minimum order is 10 units (one box) per reference, with vials shipped in boxes of 10. For white-label, a one-time label setup fee of EUR 180 applies to orders under 100 units and is waived from 100 units upward, which makes a first branded run inexpensive to trial before scaling.

Per-vial pricing that rewards combined volume

Tirzepatide 10 mg is priced per vial, with volume tiers applied to the combined total units of the whole order, not stacked per line:

| Combined units | Price / vial | Discount |

|---|---|---|

| 100 | EUR 62.00 | base |

| 300 | EUR 50.84 | -18% |

| 500 | EUR 46.50 | -25% |

| 1000 | EUR 42.16 | -32% |

Because the tier is triggered by the combined order, a distributor can mix references and still push the whole basket into a deeper discount band, which is where margin is made on resale.

Documentation is the due-diligence layer

A credible research reagent is only as good as its paper trail. Every Tirzepatide batch is manufactured to >=98% HPLC purity and ships with an independent per-batch Certificate of Analysis covering HPLC and heavy metals. The box itself carries the Peptworks label and a unique QR code that links to *that batch's* CoA, verifiable through checkpoint tooling (Peptworks). For a reseller, that traceability is what lets your own customers verify what they received, without you fielding every question.

Payment and operational fit

Payment is by USDC bank transfer / invoice rather than card, which aligns with standard B2B procurement and accounting. The storefront runs in 10 languages (ES, EN, DE, FR, PT, IT, NL, PL, CS, EL), so a multi-market distributor can source and quote in the language of each account.

A short sourcing checklist

• Confirm the stock is physically in the EU (lead time and customs risk).
• Decide bulk vs white-label per order; budget the EUR 180 setup only under 100 units.
• Model your basket to the next combined-volume tier before confirming.
• Keep the batch CoA and QR on file for your own compliance and resale.
• Verify every claim in your own listings stays within Research Use Only framing.

Sourced this way, Tirzepatide becomes a low-friction addition to an EU research-peptide catalogue: documented, branded to you, and delivered without customs drag.